/PRNewswire/ Invitae (OTC: NVTA), a leading medical genetics company, today announced new studies to be presented at the American Society of Breast Surgeons.
Potentially practice changing study suggests biopsy unnecessary for some with breast cancer healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Operator: Good morning and thank you for standing by. Currently, all participants are in a listen-only mode. After management s discussion, there will be a question-and-answer session.
Kubtec, a Stratford-based specimen imaging company, has introduced the Mozart iQ 3D Margin Management System as its latest advancement in breast cancer surgery.